NHS gets Wegovy delivery: Why is the weight-loss jab so hard to get access to?

The burden-loss injection Wegovy is without doubt one of the most profitable new prescribed drugs, however many individuals who need it will possibly’t truly entry it.

In most nations in Europe, Wegovy hasn’t but been launched, regardless of anticipated excessive demand. Within the US, one of many few locations the place it’s out there, producer Novo Nordisk has been making an attempt to restrict the quantity of people that begin taking the drugs.

This isn’t the standard behaviour of a …